These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 34839260)

  • 1. Discontinuation of PTH therapy amplifies bone loss by increasing oxidative stress: An event ameliorated by sequential IL-17 neutralizing antibody therapy.
    Singh KB; Rai R; Khanka S; Singh D
    Biomed Pharmacother; 2022 Jan; 145():112390. PubMed ID: 34839260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional block of IL-17 cytokine promotes bone healing by augmenting FOXO1 and ATF4 activity in cortical bone defect model.
    Dixit M; Singh KB; Prakash R; Singh D
    Osteoporos Int; 2017 Jul; 28(7):2207-2220. PubMed ID: 28341898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maintenance of increased bone mass after PTH withdrawal by sequential medicarpin treatment via augmentation of cAMP-PKA pathway.
    Sharma K; Awasthi P; Prakash R; Khanka S; Bajpai R; Sahasrabuddhe AA; Goel A; Singh D
    J Cell Biochem; 2022 Nov; 123(11):1762-1779. PubMed ID: 35959633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of PTH (1-34) with anti-IL17 prevents bone loss by inhibiting IL-17/N-cadherin mediated disruption of PTHR1/LRP-6 interaction.
    Mansoori MN; Shukla P; Singh D
    Bone; 2017 Dec; 105():226-236. PubMed ID: 28935557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cellular and clinical parameters of anabolic therapy for osteoporosis.
    Rosen CJ
    Crit Rev Eukaryot Gene Expr; 2003; 13(1):25-38. PubMed ID: 12839095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential transcriptional effects of PTH and estrogen during anabolic bone formation.
    von Stechow D; Zurakowski D; Pettit AR; Müller R; Gronowicz G; Chorev M; Otu H; Libermann T; Alexander JM
    J Cell Biochem; 2004 Oct; 93(3):476-90. PubMed ID: 15372627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of Gsα in the Postnatal Skeleton Leads to Low Bone Mass and a Blunted Response to Anabolic Parathyroid Hormone Therapy.
    Sinha P; Aarnisalo P; Chubb R; Poulton IJ; Guo J; Nachtrab G; Kimura T; Swami S; Saeed H; Chen M; Weinstein LS; Schipani E; Sims NA; Kronenberg HM; Wu JY
    J Biol Chem; 2016 Jan; 291(4):1631-1642. PubMed ID: 26598522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving Combination Osteoporosis Therapy in a Preclinical Model of Heightened Osteoanabolism.
    Shao Y; Hernandez-Buquer S; Childress P; Stayrook KR; Alvarez MB; Davis H; Plotkin LI; He Y; Condon KW; Burr DB; Warden SJ; Robling AG; Yang FC; Wek RC; Allen MR; Bidwell JP
    Endocrinology; 2017 Sep; 158(9):2722-2740. PubMed ID: 28637206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermittent parathyroid hormone therapy to increase bone formation.
    Thomas T
    Joint Bone Spine; 2006 May; 73(3):262-9. PubMed ID: 16563840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amelioration of type I diabetes-induced osteoporosis by parathyroid hormone is associated with improved osteoblast survival.
    Motyl KJ; McCauley LK; McCabe LR
    J Cell Physiol; 2012 Apr; 227(4):1326-34. PubMed ID: 21604269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propranolol Promotes Bone Formation and Limits Resorption Through Novel Mechanisms During Anabolic Parathyroid Hormone Treatment in Female C57BL/6J Mice.
    Treyball A; Bergeron AC; Brooks DJ; Langlais AL; Hashmi H; Nagano K; Barlow D; Neilson RJ; Roy TA; Nevola KT; Houseknecht KL; Baron R; Bouxsein ML; Guntur AR; Motyl KJ
    J Bone Miner Res; 2022 May; 37(5):954-971. PubMed ID: 35122666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential of parathyroid hormone as a therapy for osteoporosis.
    Rubin MR; Bilezikian JP
    Int J Fertil Womens Med; 2002; 47(3):103-15. PubMed ID: 12081255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of parathyroid hormone peptides on the peripheral skeleton of postmenopausal women. A systematic review.
    Metcalf LM; Aspray TJ; McCloskey EV
    Bone; 2017 Jun; 99():39-46. PubMed ID: 28286298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The anabolic action of intermittent parathyroid hormone on cortical bone depends partly on its ability to induce nitric oxide-mediated vasorelaxation in BALB/c mice.
    Gohin S; Carriero A; Chenu C; Pitsillides AA; Arnett TR; Marenzana M
    Cell Biochem Funct; 2016 Mar; 34(2):52-62. PubMed ID: 26834008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CREM deficiency in mice alters the response of bone to intermittent parathyroid hormone treatment.
    Liu F; Lee SK; Adams DJ; Gronowicz GA; Kream BE
    Bone; 2007 Apr; 40(4):1135-43. PubMed ID: 17275432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of PTH on bone structural properties].
    Ito M
    Clin Calcium; 2012 Mar; 22(3):335-41. PubMed ID: 22370300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parathyroid hormone temporal effects on bone formation and resorption.
    Kroll MH
    Bull Math Biol; 2000 Jan; 62(1):163-88. PubMed ID: 10824426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normal epidermal growth factor receptor signaling is dispensable for bone anabolic effects of parathyroid hormone.
    Schneider MR; Dahlhoff M; Andrukhova O; Grill J; Glösmann M; Schüler C; Weber K; Wolf E; Erben RG
    Bone; 2012 Jan; 50(1):237-44. PubMed ID: 22056328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased oxidative stress and greater bone anabolism in the aged, when compared to the young, murine skeleton with parathyroid hormone administration.
    Jilka RL; Almeida M; Ambrogini E; Han L; Roberson PK; Weinstein RS; Manolagas SC
    Aging Cell; 2010 Oct; 9(5):851-67. PubMed ID: 20698835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial maintenance of extra cancellous bone mass by antiresorptive agents after discontinuation of human parathyroid hormone (1-38) in right hindlimb immobilized rats.
    Ma Y; Jee WS; Chen Y; Gasser J; Ke HZ; Li XJ; Kimmel DB
    J Bone Miner Res; 1995 Nov; 10(11):1726-34. PubMed ID: 8592950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.